Xia Wu
Shanghai Key Laboratory Of Gynecology Oncology
Shanghai, 200127, China
Shanghai, 200127, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Developing patient-derived organoids to predict PARP inhibitor response and explore resistance overcoming strategies in ovarian cancer.
Journal: Pharmacological research
Published: December 27, 2021
The role of patient-derived ovarian cancer organoids in the study of PARP inhibitors sensitivity and resistance: from genomic analysis to functional testing.
Journal: Journal of experimental & clinical cancer research : CR
Published: May 06, 2021
Niraparib as Maintenance Therapy in Germline ATM-mutated and Somatic BRCA2-mutated Ovarian Cancer with Brain Metastases: A Case Report and Literature Review.
Journal: OncoTargets and therapy
Published: September 10, 2020
Curcumin protects cardiomyopathy damage through inhibiting the production of reactive oxygen species in type 2 diabetic mice.
Journal: Biochemical and biophysical research communications
Published: April 25, 2020
Anti-angiogenesis therapy overcomes the innate resistance to PD-1/PD-L1 blockade in VEGFA-overexpressed mouse tumor models.
Journal: Cancer immunology, immunotherapy : CII
Published: November 05, 2019
Primary and acquired resistance to PD-1/PD-L1 blockade in cancer treatment.
Journal: International immunopharmacology
Published: February 16, 2017
Ovarian hyperstimulation syndrome in a spontaneous pregnancy with invasive mole.
Journal: The journal of obstetrics and gynaecology research
Published: June 25, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026